Floatz logo

ceftazidime

Pulmonary Exacerbation

Association Nationale pour les Traitements A Domicile, les Innovations et la RechercheSmall moleculePhase 4 / ApprovedDormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pulmonary Exacerbation cohort.

Asset / SponsorPhaseRating
Novo Rapid Insulin
Hadassah Medical Organization
N/AD
Diluent
Hadassah Medical Organization
N/AD
Insulin Aspart
Hadassah Medical Organization
N/AD

Same molecule, other indications

ceftazidime is also rated in:

acute myeloid leukemiaDormant
B
Indicative ·
61 / 100
View asset →
Neutropenic FeverDormant
B
Indicative ·
61 / 100
View asset →
Febrile Neutropenia (FN)Dormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →